Topical pharmaceutical composition for cervical vertebra rehabilitation

A technology for external application of medicines and compositions, applied in the field of cervical spondylosis treatment medicines, can solve the problems of high surgical risk, unbearable patient suffering, weak gastrointestinal function, etc., and achieve the effect of effective treatment.

Inactive Publication Date: 2019-08-27
贾树森
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Now there are three treatment methods for cervical spondylosis: 1. Neck traction and physical therapy, the effect of physical therapy is not obvious, especially for the acute attack period, it is close to invalid
2. Cervical spine surgery has high surgical risk and high cost
3. Drug treatment, application of dehydration drugs, painkillers, neurotrophic drugs, etc. Although drug therapy is effective, it will cause great harm to the stomach and intestines. Most patients with cervical spondylosis are middle-aged and elderly people with weak gastrointestinal function. Long-term medication makes the patients miserable. Word

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] An external pharmaceutical composition for cervical spine rehabilitation, comprising the following components by weight:

[0024] Tetracycline tablets 20g, vitamin B1 3 g, vitamin B6 3 g, complex vitamin B injection 60ml, gentamicin injection 60ml, petrolatum 20g,

[0025] The compound vitamin B injection is a compound preparation, and its components are: every 2ml contains vitamin B1 20mg, vitamin B22mg, vitamin B6 2mg, nicotinamide 50mg, sodium d-pantothenate 1mg;

[0026] The specification of the gentamicin injection is: every 2ml contains 80,000 units.

Embodiment 2

[0028] An external pharmaceutical composition for cervical spine rehabilitation, comprising the following components by weight:

[0029] Tetracycline tablets 30g, vitamin B1 1g, vitamin B6 1g, complex vitamin B injection 30ml, gentamicin injection 30ml, petrolatum 40g,

[0030] The compound vitamin B injection is a compound preparation, and its components are: every 2ml contains vitamin B1 20mg, vitamin B22mg, vitamin B6 2mg, nicotinamide 50mg, sodium d-pantothenate 1mg;

[0031] The specification of the gentamicin injection is: every 2ml contains 80,000 units.

Embodiment 3

[0033] An external pharmaceutical composition for cervical spine rehabilitation, comprising the following components by weight:

[0034] Tetracycline tablets 25g, vitamin B1 2g, vitamin B6 2g, complex vitamin B injection 50ml, gentamicin injection 50ml, vaseline 30g,

[0035] The compound vitamin B injection is a compound preparation, and its components are: every 2ml contains vitamin B1 20mg, vitamin B22mg, vitamin B6 2mg, nicotinamide 50mg, sodium d-pantothenate 1mg;

[0036] The specification of the gentamicin injection is: every 2ml contains 80,000 units.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a topical pharmaceutical composition for cervical vertebra rehabilitation. The pharmaceutical composition is used for external application of cervical vertebra, is evolutionaryin effect, and directly acts on focuses; the muscle spasm is relieved and cervical spondylosis symptoms such as dizziness, headache, and neck stiffness are effectively alleviated through the synergistic effect of various medicines. The pharmaceutical composition is prepared from the following components: tetracycline, vitamin B1, vitamin B6, vitamin B complex injection, gentamicin injection, andpetrolatum, wherein the vitamin B complex injection is a compound preparation, and the components of the vitamin B complex injection are as follows: each 2 ml of the injection contains 20 mg of vitamin B1, 2 mg of vitamin B2, 2 mg of vitamin B6, 50 mg of niacinamide, and 1 mg of sodium dextropantothenate; paste is prepared by pulverizing the topical pharmaceutical composition and mixed, then the paste is applied to the back of the neck, and the application is repeated once every 4-6 hours.

Description

technical field [0001] The invention relates to an external pharmaceutical composition for cervical spine rehabilitation, which belongs to the technical field of medicines for treating cervical spondylosis. Background technique [0002] Cervical spondylosis, also known as cervical syndrome, is a general term for cervical osteoarthritis, hypertrophic spondylitis, cervical nerve root syndrome, and cervical disc herniation. It is a disease based on degenerative pathological changes. Mainly due to long-term cervical strain, bone hyperplasia, or intervertebral disc herniation, ligament thickening, cervical spinal cord, nerve root or vertebral artery are compressed, and a series of clinical syndromes of dysfunction appear. Manifested as vertebral instability and loosening; nucleus pulposus herniation or prolapse; bone spur formation; ligament hypertrophy and secondary spinal canal stenosis, etc., which stimulate or compress adjacent nerve roots, spinal cord, vertebral artery and c...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/65A61K31/51A61K31/4415A61K31/7036A61K31/525A61K31/455A61K31/197A61K31/714A61K38/48A61P19/08A61P19/02A61K35/60A61K36/535A61K31/045
CPCA61K9/0014A61K31/045A61K31/197A61K31/4415A61K31/455A61K31/51A61K31/525A61K31/65A61K31/7036A61K31/714A61K35/60A61K36/535A61K38/4873A61P19/02A61P19/08C12Y304/22004A61K2300/00
Inventor 贾树森贾海飞代亚丽贾鑫泽
Owner 贾树森
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products